Archives

Program funded by the Bill & Melinda Gates Foundation will use ReiThera’s GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV ROME, [...]

ROME, Italy, October 29th, 2021 – ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products [...]